Bio-Techne (TECH) Total Non-Current Liabilities (2014 - 2026)

Bio-Techne's Total Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $2.5 billion for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities fell 3.79% year-over-year to $2.5 billion; the TTM figure through Mar 2026 stood at $2.5 billion (down 3.79% YoY), while the FY2025 annual figure was $2.5 billion, down 5.94% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $2.5 billion, up from $2.5 billion in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $2.7 billion in Q3 2023, with the low at $2.3 billion in Q1 2022.
• The 5-year median for Total Non-Current Liabilities is $2.6 billion (2023), against an average of $2.6 billion.
• The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities increased 17.39% in 2023, then declined 7.87% in 2025.
• Bio-Techne's Total Non-Current Liabilities stood at $2.4 billion in 2022, then advanced by 15.36% to $2.7 billion in 2023, then dropped by 2.0% to $2.7 billion in 2024, then decreased by 6.0% to $2.5 billion in 2025, then gained by 1.17% to $2.5 billion in 2026.
• Business Quant data shows TECH's Total Non-Current Liabilities at $2.5 billion in Q1 2026, $2.5 billion in Q4 2025, and $2.5 billion in Q3 2025.